Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
scientific article
Author/s
author: Marco Colleoni, Fabio Puglisi, Prudence Francis, Harold J. Burstein, Olivia Pagani, Aron Goldhirsch, Meredith M Regan, Karin Ribi, Barbara A Walley, Gini F. Fleming, Carlo Tondini, Graziella Pinotti, Thomas Ruhstaller, Karen L Price, Weixiu Luo, Simon Spazzapan, Lorenzo Pavesi, Vani Parmar
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.